Acorah Software Products - Accounts Production 15.0.600 false true 30 June 2023 1 July 2022 false true No description of principal activity 1 July 2023 30 June 2024 30 June 2024 13475230 Dr Qaisar Jaffri iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13475230 2023-06-30 13475230 2024-06-30 13475230 2023-07-01 2024-06-30 13475230 frs-bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 13475230 frs-bus:FilletedAccounts 2023-07-01 2024-06-30 13475230 frs-bus:Micro-entities 2023-07-01 2024-06-30 13475230 frs-bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 13475230 frs-bus:Director1 2023-07-01 2024-06-30 13475230 2022-06-30 13475230 2023-06-30 13475230 2022-07-01 2023-06-30
Registered number: 13475230
Talking Aesthetics Limited
Financial Statements
For The Year Ended 30 June 2024
MAW Accountants
CPAA
33 Thingwall Road
Wirral
CH61 3UE
Balance Sheet
Registered number: 13475230
2024 2023
£ £
Current assets 1 1
NET CURRENT ASSETS 1 1
TOTAL ASSETS LESS CURRENT LIABILITIES 1 1
NET ASSETS 1 1
CAPITAL AND RESERVES 1 1

Notes

1. General Information
Talking Aesthetics Limited is a private company, limited by shares, incorporated in England & Wales, registered number 13475230 . The registered office is Saltney House Chesterbank Business Park, River Lane, Chester, CH4 8SL.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Qaisar Jaffri
Director
14/10/2024